0001434316-11-000002.txt : 20110420 0001434316-11-000002.hdr.sgml : 20110420 20110419180148 ACCESSION NUMBER: 0001434316-11-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110420 DATE AS OF CHANGE: 20110419 EFFECTIVENESS DATE: 20110420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FATE THERAPEUTICS INC CENTRAL INDEX KEY: 0001434316 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-158650 FILM NUMBER: 11768997 BUSINESS ADDRESS: STREET 1: 3535 GENERAL ATOMICS COURT STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858.875.1803 MAIL ADDRESS: STREET 1: 3535 GENERAL ATOMICS COURT STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0704 D LIVE 0001434316 FATE THERAPEUTICS INC 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA CALIFORNIA 92121 858.875.1803 DELAWARE None None Corporation true 2007 Scott Wolchko c/o Fate Therapeutics Inc. 3535 General Atomics Court, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer John Mendlein c/o Fate Therapeutics Inc. 3535 General Atomics Court, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Director Amir Nashat c/o Polaris Venture Partners 1000 Winter Street, Suite 3350 Waltham MA MASSACHUSETTS 02451 Director Carl Weissman c/o OVP Venture Partners 1010 Market Street Kirkland WA WASHINGTON 98033 Director Bryan E. Roberts c/o Venrock Associates 3340 Hillview Avenue Palo Alto CA CALIFORNIA 94304 Director Robert T. Nelsen c/o ARCH Venture Partners 8725 West Higgins Road, Suite 290 Chicago IL ILLINOIS 60631 Director Daniel Shoemaker c/o Fate Therapeutics Inc. 3535 General Atomics Court, Suite 200 La Jolla CA CALIFORNIA 92121 Executive Officer Biotechnology Decline to Disclose 06 false 2011-03-30 false true false 0 1000000 1000000 0 false 1 0 0 0 false FATE THERAPEUTICS INC /s/ Scott Wolchko Scott Wolchko Chief Financial Officer 2011-04-18